Christoph Seubert, MD
After completing a two-year fellowship in cardiac research funded by
the American Heart Association, my research program has evolved to encompass
three major areas: 1) clinically oriented anesthesia research, 2) neuronal
effects of aromatic amino acids, and 3) drug design and development of novel
drugs, including nanotechnology applications in medicine.
Clinically oriented anesthesia research. My major clinical research project
addresses a question vital to the medical care of astronauts, namely how
adaptation to weightlessness changes the response to general anesthesia. For
this NASA-funded endeavor, I have assembled an intercollegiate research team
from the Department of Anesthesiology, the College of Pharmacy, and the
College of Allied Health Professions to study the changes in
pharmacokinetics, drug effect, and recovery from anesthesia in a randomized
cross-over study of volunteers exposed to an earth-based simulation of
weightlessness. A recent new clinical research direction is the study of
effects of anesthesia on long-term mortality in a cohort of women undergoing
surgery for gynecologic tumors.
Neuronal effects of aromatic amino acids. Although phenylketonuria is the
most frequent biochemical cause of mental retardation and is a
well-researched prototypical genetic disease, the pathogenesis of its
neurological symptoms is poorly understood. In close collaboration with Dr.
Martynyuk, we have described the neuronal effects of L-phenylalanine, the
pathogenetic agent of phenylketonuria. These studies span cellular
electrophysiology in neuronal cultures and brain slices, receptor
pharmacology, mass spectrometry, molecular biology, and whole animal studies
in the genetic mouse model of phenylketonuria. Because of robust results
across various experimental settings, we plan to take these studies from
bench to bedside in the form of a pilot study in phenylketonuria patients,
which is already approved and supported by the NIH-funded General Clinical
Research Center. Further directions of this research effort have focused on
neuroprotective, neuro-modulatory and anti-epileptic effects of aromatic
amino acids.
| 4: |
Glushakov AV, Glushakova O, Varshney M, Bajpai
LK, Sumners C, Laipis PJ, Embury JE, Baker SP,
Otero DH, Dennis DM, Seubert CN, Martynyuk AE. |
| |
Long-term changes in
glutamatergic synaptic transmission in
phenylketonuria.
Brain. 2005 Feb;128(Pt 2):300-7. Epub
2005 Jan 5. |
|